A carregar...
Hypothesis: What is the Best We Can Do with Hydroxychloroquine for COVID-19?
There are widespread anecdotal reports of seemingly successful treatment among the early (three to seven days from symptoms) stage coronavirus disease 2019 (COVID-19) patients with the drug hydroxychloroquine (HCQ), and randomized placebo-controlled trials of HCQ in outpatient settings are underway....
Na minha lista:
| Publicado no: | Clin Epidemiol |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7585824/ https://ncbi.nlm.nih.gov/pubmed/33116907 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CLEP.S277889 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|